Combined blockade of signalling pathways shows marked anti-tumour potential in phaeochromocytoma cell lines.
Currently, there is no completely effective therapy available for metastatic phaeochromocytomas (PCCs) and paragangliomas. In this study, we explore new molecular targeted therapies for these tumours, using one more benign (mouse phaeochromocytoma cell (MPC)) and one more malignant (mouse tumour tis...
Main Authors: | Nölting, S, Garcia, E, Alusi, G, Giubellino, A, Pacak, K, Korbonits, M, Grossman, AB |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado: |
2012
|
Títulos similares
-
Combined Blockade of Several Signalling Pathways Shows Marked Anti-Tumor Potential in Two Novel Mouse Phaeochromocytoma Cell Lines
por: Noelting, S, et al.
Publicado: (2012) -
The dangers of unopposed beta-adrenergic blockade in phaeochromocytoma.
por: Sheaves, R, et al.
Publicado: (1995) -
Combination of 13-Cis retinoic acid and lovastatin: marked antitumor potential in vivo in a pheochromocytoma allograft model in female athymic nude mice.
por: Nölting, S, et al.
Publicado: (2014) -
Treatment of malignant phaeochromocytoma, paraganglioma and carcinoid tumours with 131I-metaiodobenzylguanidine.
por: Bomanji, J, et al.
Publicado: (1993) -
Combined inhibition of mTORC1 and mTORC2 signaling pathways is a promising therapeutic option in inhibiting pheochromocytoma tumor growth: in vitro and in vivo studies in female athymic nude mice.
por: Giubellino, A, et al.
Publicado: (2013)